Developing Computerised CBT for Adults With OCD

NCT ID: NCT02398045

Last Updated: 2016-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to pilot a new computerised cognitive behavioural therapy programme for a small case series of adults with obsessive-compulsive disorder. The investigators hypothesise that the findings will demonstrate improvements in symptomatology following the programme. The programme will have longer-term aims of being rolled out over a number of IAPT services within the NHS, reducing waiting lists and increasing therapist time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive-compulsive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Computerised CBT

Computerised CBT for OCD

Group Type EXPERIMENTAL

Computerised CBT for OCD

Intervention Type OTHER

Computerised CBT for OCD

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computerised CBT for OCD

Computerised CBT for OCD

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18 or over with OCD as defined by DSM-IV who are seeking CBT.
* The patient describes their OCD as their main problem and scores between 14 and 30 on the YBOCS (Goodman et al, 1989). A score above 30 is in the severe range and indicates that the CBT should probably be therapist delivered.
* Able to use self-help materials in English and answer written questionnaires.
* Able to access the internet (either at home or in a public library or drop in centre or at the clinic).
* Have a current episode of OCD of more than 6 months in duration.

Exclusion Criteria

* Significant and complex co-morbidity (e.g. significant personality disorder, severe depression or alcohol dependence, which requires longer therapy or is more difficult to treat). Such patients are likely to be part of a Community Mental Health team or be funded by the Department of Health's National Specialist Commissioning Team scheme for severe treatment refectory OCD.
* Current active suicidal intent or severe self-neglect that requires hospitalisation.
* The patient has a primary problem of compulsive hoarding (as such patients are more complex or are more likely to be under a Community Mental Health team).
* Continuing to receive another form of psychotherapy.
* Has received CBT for OCD in the past year.
* A participant may be taking an anti-depressant for OCD but must be on a stable dose for at least 12 weeks prior to entry in the trial with no plans to alter the dose during the trial period. There must also be no plan to commence on an anti-depressant or anti-psychotic medication. (Participants excluded because of their current or planned medication may be offered a further assessment for the trial after being on a stable dose
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

South London and Maudsley NHS Foundation Trust

OTHER

Sponsor Role collaborator

Institute of Psychiatry, London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Veale

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Veale, MRCPsych

Role: PRINCIPAL_INVESTIGATOR

Institute of Psychiatry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Anxiety Disorders and Trauma

London, London, United Kingdom

Site Status RECRUITING

South London and Maudsley NHS Trust

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Veale, MRCPsych

Role: CONTACT

02032283212

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Veale, Consultant Psychiatrist

Role: primary

442032283212

David M Veale

Role: primary

0203 228 3461

Nell ET Ellison

Role: backup

0203 228 3212

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

658-PAHTLZB

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CCBT-1111

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Priming CBT with RTMS for OCD
NCT06840951 RECRUITING PHASE1